中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

10 records (took 0.03 seconds)

    Combination therapy to prevent and treat diarrhea induced by cancer treatment
    2.
    发明申请
    Combination therapy to prevent and treat diarrhea induced by cancer treatment 审中-公开
    联合治疗预防和治疗由癌症治疗引起的腹泻

    公开(公告)号：US20050245456A1

    公开(公告)日：2005-11-03

    申请号：US11119211

    申请日：2005-04-28

    Applicant: Diane Healey ,  Jean Beebe ,  James O'Leary ,  W. Roberts ,  Anthony Tolcher ,  Mark Huberman

    Inventor： Diane Healey ,  Jean Beebe ,  James O'Leary ,  W. Roberts ,  Anthony Tolcher ,  Mark Huberman

    IPC: A61K31/138 ,  A61K31/425 ,  A61K31/56 ,  A61K38/08

    CPC classification number: A61K45/06 ,  A61K31/138 ,  A61K31/425 ,  A61K31/56 ,  A61K2300/00

    Abstract: This invention relates to a method of treating drug side effects in cancer treatment. More particularly, the present invention relates to preventing, reducing, alleviating, or reversing diarrhea caused by the administration of the isothiazole 3-(4-Bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide in the treatment of cancer comprising the step of administering to a patient in need of such treatment, prior to, simultaneously, or sequentially, a therapeutically effective amount of 3-(4-Bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of an anti-diarrheal agent, a bulking agent, or an anti-estrogen. The combinations of the present invention may optionally include an anti-hypertensive agent.

    Abstract translation: 本发明涉及一种治疗癌症治疗药物副​​作用的方法。 更具体地说，本发明涉及通过给予异噻唑3-（4-溴-2,6-二氟 - 苄氧基）-5- [3-（4-吡咯烷-1-基）苯基）苯甲酸酯而引起的腹泻的预防，减轻，减轻或逆转， 丁基） - 脲基] - 异噻唑-4-羧酸酰胺在治疗癌症中的用途包括以下步骤：在需要这种治疗的患者之前，同时或依次给予治疗有效量的3 - （4-溴-2,6-二氟 - 苄氧基）-5- [3-（4-吡咯烷-1-基 - 丁基） - 脲基] - 异噻唑-4-羧酸酰胺或其药学上可接受的盐，和 治疗有效量的抗腹泻剂，填充剂或抗雌激素。 本发明的组合可以任选地包括抗高血压剂。

    Combination therapy for hyperproliferative disease
    7.
    发明申请
    Combination therapy for hyperproliferative disease 审中-公开
    过度增生性疾病的联合治疗

    公开(公告)号：US20070197517A1

    公开(公告)日：2007-08-23

    申请号：US10643546

    申请日：2003-08-19

    Applicant: Jitesh Jani ,  Jean Beebe ,  Tracey Schaeffer ,  Diane Healey ,  Karen Ferrante ,  James O'Leary

    Inventor： Jitesh Jani ,  Jean Beebe ,  Tracey Schaeffer ,  Diane Healey ,  Karen Ferrante ,  James O'Leary

    IPC: A61K31/41 ,  A61K31/35 ,  A61K31/53 ,  C07D239/42

    CPC classification number: A61K31/282 ,  A61K31/337 ,  A61K31/425 ,  A61K31/427 ,  A61K31/454 ,  A61K31/473 ,  A61K31/4745 ,  A61K31/496 ,  A61K31/513 ,  A61K31/555 ,  A61K31/704 ,  A61K31/7048 ,  A61K2300/00

    Abstract: This invention relates a method of treating hyperproliferative diseases. More particularly, the present invention relates to a method of treating hyperproliferative diseases, such as cancer, comprising the step of administering to a mammal in need of such treatment, either simultaneously or sequentially, (i) a therapeutically effective amount of a taxane derivative, a platinium coordination complex selected from the group consisting of carboplatin, tetraplatin, and topotecan, a nucleoside analog selected from the group consisting of gemcitabine hydrochloride and 5-FU, an anthracycline, a topoisomerase selected from the group consisting of etoposide, teniposide, amsacrine, topotecan, and Camptosar®, an aromatase inhibitor; and (ii) a therapeutically effective amount of an isothiazole derivative. The combinations of the present invention may optionally include an anti-hypertensive agent. This invention also relates to pharmaceutical compositions useful in the treatment of hyperproliferative diseases in mammals, containing such combinations. The present invention also relates to kits having a first compartment with a compound of formula 1 and a second compartment containing a taxane derivative, a platinum coordination complex, a nucleoside analog, an anthracycline, a topoisomerase inhibitor, or an aromatase inhibitor and a third compartment containing an anti-hypertensive agent.

    Abstract translation: 本发明涉及一种治疗过度增殖性疾病的方法。 更具体地说，本发明涉及治疗过度增殖性疾病如癌症的方法，其包括以下步骤：同时或依次给予需要这种治疗的哺乳动物，（i）治疗有效量的紫杉烷衍生物， 选自卡铂，四铂和托泊替康的铂配位络合物，选自盐酸吉西他滨和5-FU的核苷类似物，蒽环类，拓扑异构酶，其选自依托泊苷，替尼泊苷，安吖啶， 拓扑替康和Camptosar（芳香酶抑制剂）; 和（ii）治疗有效量的异噻唑衍生物。 本发明的组合可以任选地包括抗高血压剂。 本发明还涉及可用于治疗哺乳动物中含有这种组合的过度增殖性疾病的药物组合物。 本发明还涉及具有具有式1化合物的第一隔室和含有紫杉烷衍生物，铂配位络合物，核苷类似物，蒽环类，拓扑异构酶抑制剂或芳香酶抑制剂和第三隔室的第二隔室的试剂盒 含有抗高血压药。

Patent Agency Ranking